海外の前立腺摘除術のベスト医師 — ページ3

前立腺の開腹手術および閉鎖手術の両方を専門とするテメル医師は、Büyük Anadolu病院にて包括的な治療オプションを提供しています。

• 泌尿器がん手術の専門家
• レーザー結石破砕術（RIRS）の熟練者
• 尿失禁治療を提供
• 不妊治療のソリューションを提供

世界有数の癌専門病院であるメモリアル・スローン・ケタリング癌センターにて泌尿器腫瘍学の研修を修了。現在はキロンサルド・マルベーリャ（Quirónsalud Marbella）の泌尿器科部門を統括。

• ロボット手術および下部尿路手術を専門とする
• マラガ泌尿器外科研究所の共同設立者
• 泌尿器疾患に関する多数の論文を発表
• カルロス・ハヤ病院の腎移植チームメンバー

イ・チュニョン博士は、漢陽大学校医学部で医学博士号を取得した泌尿器科医です。臨床専門分野は、腎結石・尿路結石（ESWL）、前立腺疾患（前立腺肥大症、前立腺がん、前立腺炎）、性機能障害、パイプカット（精管切除術）、膀胱炎、尿失禁、排尿障害です。

漢陽大学校病院の院長を歴任しました。漢陽大学校医学部泌尿器科学教室の主任教授および部長を務めました。韓国内視鏡泌尿器科学会の会長、後に名誉会長を務めました。また、国際泌尿器科学会（Société Internationale d'Urologie）の理事も務めました。

国際的な役割としては、UCLAの客員研究員やテュービンゲン大学の客員教授を歴任しました。EBSの「ベストドクターズ」に2度出演し、前立腺疾患や腎結石・尿路結石について解説しました。

ブルース・パトリック・ドス・サントス・マルカーノは、バルセロナのキロン病院において、技術的な正確さと審美的なビジョンを融合させた形成外科を提供しています。

• バル・デブロン大学病院の形成・美容・再建外科専門医
• 米国形成外科医会（ASPS）会員
• パルク・タウリ財団にてマイクロサージャリー技術を習得
• 多数の科学論文の著者および共著者

2018年より腫瘍内科を専門とするアレムダル医師は、メディカルパーク・アンタルヤ病院コンプレックスにて前立腺がん治療に注力しています。

• 20 年 内科および腫瘍学における経験
• 主要な医療機関であるアクデニズ大学で研修
• JCI認証を受けた近代的な病院コンプレックスに勤務
• 多様な病院環境における深い経験

オズカン・オヌク准教授は、Medical Park Bahcelievler病院にて前立腺がん治療に重点を置く泌尿器科専門医です。

• _doctor_9727_年以上の泌尿器科経験
• 前立腺がんおよび泌尿器外科に関する25本以上の研究論文を発表
• 尿失禁に対する低侵襲技術を開発
• 複数の国際的な泌尿器科研究チームのメンバー

ジョージ・タイ医師は、TURP（経尿道的前立腺切除術）やレーザー治療を含む低侵襲前立腺手術を専門としており、正確性と患者の快適さを保証します。

• 低侵襲、腹腔鏡下、内視鏡下、およびロボット支援による泌尿器科手術の専門家
• 前立腺手術および泌尿器がん管理における高い成功率
• 現代的な医療環境において、エビデンスに基づいた高度なケアを提供

クルシャド・ゼンギン医師は、泌尿器科で_doctor_8416_年以上の経験を持ち、Lokman Hekim Akay病院で前立腺処置を専門としています。

• ハジェテペ大学およびアンカラ・ディシュカプ教育研究病院で研修
• 前立腺関連の手術および治療を専門とする
• 現在、Lokman Hekim Akay病院に勤務

Dr. Hasan Anıl Atalay is a urologist focused on uro‑oncology, reconstructive urology, and stone disease. He has expertise in laparoscopic and robotic surgery. He trained at Cerrahpaşa Faculty of Medicine and Istanbul Training & Research Hospital. He completed advanced training at Memorial Sloan Kettering Cancer Center (2010–2011) and World Laparoscopy Hospital (2019–2020).

He has authored more than 30 peer‑reviewed papers (2016–2021). Topics include CT texture to predict ESWL outcomes, VI‑RADS in bladder cancer, renal function after partial nephrectomy, PCNL fluoroscopy and stone metrics, sexual dysfunction, urosepsis biomarkers, and 3D models for PCNL and patient education. He is a member of the European Urology Association, the Turkish Urology Association, and the Urological Surgery Association.

ユルダクル教授は泌尿器腫瘍学を専門とし、前立腺がん治療のリーダーであるクリーブランド・クリニックでフェローシップ研修を修了しました。

• 神経温存技術に重点を置いた前立腺全摘除術を実施
• 泌尿器腫瘍学の転帰に関する16本の国際論文を発表
• 複雑な症例に対する微小血管外科のトレーニングを修了
• セルチュク大学医学部教授
• 国内泌尿器科学会での講演者

泌尿器科医、外科医

ウラジーミル・ユトキン医師は、ハダッサ医療センターでの前立腺摘出術において_doctor_3603_年以上の経験を有しています。

• 1996年にエルサレム・ヘブライ大学を卒業
• 顎関節症を専門とする
• 英語、ヘブライ語、ロシア語に堪能

キム・ヒョンフェ教授は泌尿器がん外科医であり、前立腺がん、腎臓がん、およびロボット支援手術を専門としています。明知（ミョンジ）病院のロボット手術センターおよび前立腺・腎臓がんセンターのセンター長を務めています。韓国初の単孔式腹腔鏡手術を執刀しました。ソウル大学校病院（SNUH）では5年間で2,300件以上のダビンチ手術を主導し、現在はダビンチXiシステムを使用しています。

ソウル大学校で医学士、修士、博士号を取得。ソウル大学校病院のロボット手術センター長および泌尿器・前立腺がんセンター長を歴任しました。大韓内視鏡・ロボット泌尿器科学会の元会長であり、大韓泌尿器科学会の評議員を務めています。WCE（世界内視鏡外科学会）最優秀腹腔鏡/ロボット論文賞、大韓泌尿器科学会最優秀論文賞のほか、数々の国家的な学術賞を受賞しています。また、ソウル大学校およびインテュイティブサージカル社との次世代ダビンチ研究にも貢献しており、これはアジア初の共同研究プロジェクトとなりました。

当医師は、2017年よりキロンサル・トレビエハ病院（Hospital Quirónsalud Torrevieja）の泌尿器科部長を務める、経験豊富な泌尿器科専門医です。ドイツのヨハネス・グーテンベルク大学で医学学位と専門資格を取得し、2007年以来、広範な臨床経験を積んでいます。専門分野は、腫瘍泌尿器科、前立腺疾患、複雑な尿路疾患など多岐にわたります。

当医師の診療における主要な焦点は、ロボット支援泌尿器科手術であり、特に前立腺がんの手術においてダビンチ手術システムを活用しています。また、『Differentialdiagnose Urologie』の章執筆など学術文献にも貢献しており、国内外の患者に対して質の高い医療を提供することに注力しています。

Jang Hyun Kyung医師は、認定泌尿器科医です。嘉泉大学ギル医療センターでレジデントおよび臨床フェローシップを修了しました。その後、高麗大学安山病院および国際聖マリア病院で泌尿器科の臨床助教授を務めました。

臨床上の関心分野は、前立腺肥大症（BPH）、尿路結石症、尿失禁および排尿障害、尿路感染症です。また、男性泌尿器科、小児泌尿器科、泌尿器科超音波検査にも注力しています。

専門職会員：韓国泌尿器科学会、韓国排尿障害学会、韓国小児泌尿器科学会、韓国尿路感染症・炎症学会、韓国泌尿器科超音波学会の正会員。現在の所属：泌尿器科医、ギブム病院。

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

ドリット・ジルバーマン医師は、イスラエルのシェバ医療センターの上級泌尿器科医です。ロボット支援手術および低侵襲泌尿器科手術のパイオニアであり、腎臓がん、膀胱がん、前立腺がんの治療を専門としています。シェバ医療センターにおけるダヴィンチ・ロボット手術プログラムの立ち上げに貢献しました。フォーブス・イスラエル誌により、国内のベストドクターの一人に選出されています。

• 泌尿器腫瘍学および内視鏡泌尿器科学に関する160以上の科学論文を執筆。
• 米国デューク大学医療センターにてフェローシップ研修を修了。
• ロボット支援前立腺全摘除術、レーザー砕石術、腎温存手術を実施。
• 米国泌尿器科学会、欧州泌尿器科学会、および内視鏡泌尿器科学会の会員。

ニール・クラインマン医師は、シェバ医療センターの結石・内視鏡泌尿器科ユニットを統括しています。複雑な腫瘍に対する腎温存レーザー手術のパイオニアです。フォーブス誌とResultMedにより、2025年および2026年のイスラエルのベストドクターに選出されました。クラインマン医師は、がん治療中に臓器機能を維持するための独自のデュアルレーザーシステムを使用しています。

• トーマス・ジェファーソン大学およびマクマスター大学で泌尿器科フェローシップを修了。
• 上部尿路がん（UTUC）、腎結石、前立腺がんに対する低侵襲治療の専門家。
• 非外科的化学アブレーションに関するOLYMPUS試験の研究者として従事。
• 米国内視鏡泌尿器科学会フェローであり、60以上の科学論文を発表。

50本以上の科学論文を発表し、イスラエル有数の癌センターで指導的役割を担うゾハール・ドタン医師は、イスラエルでも数少ないフェローシップ研修を受けた泌尿器腫瘍専門医の一人です。

• シェバ医療センター（テルアビブ大学教育病院）泌尿器科部長
• イスラエルにおけるロボット支援下前立腺全摘除術のパイオニア
• 米国臨床外科学会賞受賞
• メモリアル・スローン・ケタリング癌センターにて研修

准教授のジェム・バサタックは、Gayrettepe Florence Nightingale病院にて腹腔鏡下前立腺全摘除術を専門としています。

• _doctor_8339_年以上の泌尿器科経験
• 腹腔鏡下手術技術の訓練を受けている
• イスタンブールの複数の主要病院での勤務経験あり
• イスタンブール・ウムラニエ教育研究病院にて専門課程を修了